Respiratory Syncytial Virus Infection Among Hospitalized Infants in Four Middle-Income Countries.


Journal

Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049

Informations de publication

Date de publication:
31 Jul 2023
Historique:
received: 20 12 2022
accepted: 08 06 2023
medline: 1 8 2023
pubmed: 14 6 2023
entrez: 14 6 2023
Statut: ppublish

Résumé

Understanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies. Hospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and Philippines during respiratory seasons in 2015-2017. Medical chart review, parental interview, and post-discharge follow up were conducted. Respiratory specimens were tested using real-time RT-PCR for RSV. Infant characteristics associated with very severe illness (intensive care unit [ICU] admission or receipt of supplemental oxygen) were assessed using logistic regression to adjust for potential confounders (age, sex, study site, and preterm birth). Of 3634 enrolled hospitalized infants, 1129 (31%) tested positive for RSV. The median age of RSV-positive infants was 2.7 (IQR: 1.4-6.1) months and 665 (59%) were male. Very severe illness in 583 (52%) RSV-positive infants was associated with younger age (aOR 4.1, 95% CI: 2.6-6.5 for 0-2 compared to 9-11-months; P < .01), low weight-for-age z-score (aOR 1.9, 95% CI: 1.2-2.8; P < .01), ICU care after birth (aOR 1.6, 95% CI: 1.0-2.5; P = .048), and cesarean delivery (aOR 1.4, 95% CI: 1.0-1.8; P = .03). RSV subgroups A and B co-circulated at all sites with alternating predominance by year; subgroup was not associated with severity (aOR 1.0, 95% CI: 0.8-1.4). Nine (0.8%) RSV-positive infants died during admission or within ≤30 days of discharge, of which 7 (78%) were <6-months-old. RSV was associated with nearly a third of infant acute illness hospitalizations in four middle-income countries during the respiratory season, where, in addition to young age, factors including low weight-for-age might be important predictors of severity. RSV prevention strategies targeting young infants could substantially reduce RSV-associated hospitalizations in middle-income countries.

Sections du résumé

BACKGROUND BACKGROUND
Understanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies.
METHODS METHODS
Hospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and Philippines during respiratory seasons in 2015-2017. Medical chart review, parental interview, and post-discharge follow up were conducted. Respiratory specimens were tested using real-time RT-PCR for RSV. Infant characteristics associated with very severe illness (intensive care unit [ICU] admission or receipt of supplemental oxygen) were assessed using logistic regression to adjust for potential confounders (age, sex, study site, and preterm birth).
RESULTS RESULTS
Of 3634 enrolled hospitalized infants, 1129 (31%) tested positive for RSV. The median age of RSV-positive infants was 2.7 (IQR: 1.4-6.1) months and 665 (59%) were male. Very severe illness in 583 (52%) RSV-positive infants was associated with younger age (aOR 4.1, 95% CI: 2.6-6.5 for 0-2 compared to 9-11-months; P < .01), low weight-for-age z-score (aOR 1.9, 95% CI: 1.2-2.8; P < .01), ICU care after birth (aOR 1.6, 95% CI: 1.0-2.5; P = .048), and cesarean delivery (aOR 1.4, 95% CI: 1.0-1.8; P = .03). RSV subgroups A and B co-circulated at all sites with alternating predominance by year; subgroup was not associated with severity (aOR 1.0, 95% CI: 0.8-1.4). Nine (0.8%) RSV-positive infants died during admission or within ≤30 days of discharge, of which 7 (78%) were <6-months-old.
CONCLUSIONS CONCLUSIONS
RSV was associated with nearly a third of infant acute illness hospitalizations in four middle-income countries during the respiratory season, where, in addition to young age, factors including low weight-for-age might be important predictors of severity. RSV prevention strategies targeting young infants could substantially reduce RSV-associated hospitalizations in middle-income countries.

Identifiants

pubmed: 37313727
pii: 7197508
doi: 10.1093/jpids/piad042
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-405

Subventions

Organisme : CDC HHS
ID : HHSD2002013M53890B
Pays : United States

Investigateurs

Min Z Levine (MZ)
Laura Edwards (L)
Angel Balmaseda (A)
Guillermina Kuan (G)
Nery Sanchez (N)
Sergio Ojeda (S)
Tareq M Al-Sanouri (TM)
Ali Arbaji (A)
Lei Lanna Mendoza-Dancel (LL)
Karen Iana Cruz (K)
Diozele M Sanvictores (DM)

Informations de copyright

Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2023.

Auteurs

Holly M Biggs (HM)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Eric A F Simões (EAF)

Section of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Center for Global Health, Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado, USA.

Ilham Abu Khader (I)

The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.

Mark G Thompson (MG)

Influenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aubree Gordon (A)

Abt Associates, Inc., Atlanta, GA, USA.

Danielle R Hunt (DR)

Department of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.

Nicholas P DeGroote (NP)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Rachael M Porter (RM)

Influenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Silvia Bino (S)

Department of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.

Basima I Marar (BI)

Al-Bashir Hospital, Amman, Jordan.

Lionel Gresh (L)

Sustainable Sciences Institute, Managua, Nicaragua.

Joanne de Jesus-Cornejo (J)

Research Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.

Gayle Langley (G)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Natalie J Thornburg (NJ)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Teresa C T Peret (TCT)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Brett Whitaker (B)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Yange Zhang (Y)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lijuan Wang (L)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Mira C Patel (MC)

Influenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Meredith McMorrow (M)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

William Campbell (W)

Department of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.

Iris Hasibra (I)

Department of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.

Enkeleda Duka (E)

Pediatric Department, Mother Theresa University Hospital Center, Tirana, Albania.

Mahmoud Al-Gazo (M)

The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan.

John Kubale (J)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Felix Sanchez (F)

Hospital Infantil Manuel de Jesus Rivera, Ministry of Health, Managua, Nicaragua.

Marilla G Lucero (MG)

Research Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.

Veronica L Tallo (VL)

Research Institute for Tropical Medicine, Department of Health, Muntinlupa City, Metro Manila, Philippines.

Eduardo Azziz-Baumgartner (E)

Influenza Division, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Artan Simaku (A)

Department of Epidemiology & Control of Infectious Diseases, Institute of Public Health, Tirana, Albania.

Susan I Gerber (SI)

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH